Back to Search Start Over

Aalto Bio Reagents announces SARS nCOV 2 NP and Mabs for Omicron Variant

Source :
GlobeNewswire. December 13, 2021
Publication Year :
2021

Abstract

DUBLIN, Dec 13, 2021 (GLOBE NEWSWIRE via COMTEX) -- Aalto Bio Reagents ltd., a leading developer of critical raw materials and reagents for the development of diagnostic tests globally, announced [...]

Subjects

Subjects :
Biological products industry -- Health aspects
Diagnostic reagents -- Health aspects
Raw materials -- Health aspects
Proteins -- Health aspects
Vaccines -- Health aspects
Banking, finance and accounting industries
Business

Details

Language :
English
Database :
Gale General OneFile
Journal :
GlobeNewswire
Publication Type :
News
Accession number :
edsgcl.686570309

Tools

Authors Abstract Subjects Details